Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 14, 2023; 29(2): 390-409
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.390
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.390
Figure 5 Third-line quadruple therapy eradication rates.
A: Quadruple therapy as third-line treatment (per protocol); B: Quadruple therapy as third-line treatment (intention to treat). BQT: Bismuth quadruple therapy; N-BQT: Non-bismuth quadruple therapy.
- Citation: de Moraes Andrade PV, Monteiro YM, Chehter EZ. Third-line and rescue therapy for refractory Helicobacter pylori infection: A systematic review. World J Gastroenterol 2023; 29(2): 390-409
- URL: https://www.wjgnet.com/1007-9327/full/v29/i2/390.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i2.390